Cookies show us what works. Privacy
Cookies show us what works. Privacy
20 funds hold it · 1 straight earnings miss
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 10, 2026
Period ending
Sep 30, 2026
Earnings per share
$0.87 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Nov 13, 2026
EPS expected
$1.07 to $1.26
Revenue expected
5 analysts
Last 30 days
Analysts cutting estimates
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 10, 2026 | $0.41est. $0.87 | -52.87%miss | $12.27BAlpha Vantage | +12.9%from $10.87B |
| Jun 30, 2026Reported Aug 10, 2026 | $1.22est. $0.61 | +100.00%beat | $11.59BAlpha Vantage | +16.3%from $9.96B |
| Mar 31, 2026Reported May 8, 2026 | $0.16est. $0.29 | -44.83%miss | $7.44BAlpha Vantage | +15.5%from $6.44B |
| Dec 31, 2025Reported Mar 6, 2026 | $0.84est. $0.70 | +19.36%beat | $14.52BAlpha Vantage | +49.6%from $9.71B |
| Sep 30, 2025Reported Nov 4, 2025 | $0.30est. $0.50 | -40.00%miss | $10.87BAlpha Vantage | +17.5%from $9.25B |
| Jun 30, 2025Reported Aug 5, 2025 | $0.65est. $0.55 | +18.18%beat | $9.96BAlpha Vantage | +19.4%from $8.35B |
| Mar 31, 2025Reported May 6, 2025 | $0.40est. -$0.02 | +$0.42beat | $6.44BAlpha Vantage | +42.1%from $4.53B |
| Dec 31, 2024Reported Feb 27, 2025 | $0.94est. $0.61 | +54.10%beat | $9.71BAlpha Vantage | +384.1%from $2.01B |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $14.52B | $7.44B | $11.59B | $12.27B |
| Cost of what it sold | $12.10B | $6.11B | $9.28B | $9.92B |
| Gross profit | $2.42B | $1.34B | $2.31B | $2.35B |
| What it spent | ||||
| Research and development | $170.3M | $79.9M | $203.0M | $110.7M |
| Sales and admin | $327.5M | $264.6M | $150.5M | — |
| Other operating costs | $760.8M | $611.3M | $547.6M | $738.2M |
| Total operating expenses | $1.26B | $955.9M | $901.1M | $848.9M |
| What was left | ||||
| Operating profit | $1.16B | $381.4M | $1.41B | $1.50B |
| Interest on debt | $326.3M | $248.7M | $374.7M | $1.15B |
| Profit before tax | $754.2M | $202.9M | $1.43B | $448.9M |
| Tax | $310.0M | $12.4M | $315.5M | $57.3M |
| Net profit | $456.2M | $171.6M | $1.11B | $372.7M |
| EBITDA | $98.0M | $655.8M | $1.75B | $1.50B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
12 macro signals shaping EMBJ right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results